Artivion, Inc. (AORT) KPIs and segments
Close on Nov 13, 2026Market cap $931.24MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Artivion's business
Artivion's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medical devices($M) | 99.9 | 91.4 | 91.9 | 87.7 | 87.4 | 78.8 | 74.7 | 71.2 | 73.2 | 71.1 | 69.1 | 63.7 | |
North America($M) | 62.3 | 58.7 | 58.1 | 58.3 | 57.6 | 47.8 | 49.3 | 49.1 | 48.7 | 50.9 | 50.1 | 48.0 | |
EMEA($M) | 44.5 | 44.0 | 39.4 | 36.2 | 38.7 | 37.0 | 33.4 | 30.4 | 34.1 | 33.6 | 30.2 | 26.5 | |
Preservation services($M) | 25.9 | 24.9 | 24.1 | 25.7 | 25.5 | 20.2 | 22.6 | 24.5 | 24.8 | 26.3 | 24.5 | 24.1 | |
APAC($M) | 12.2 | 8.69 | 12.7 | 12.2 | 11.1 | 8.21 | 9.57 | 10.4 | 9.65 | 7.61 | 8.92 | 8.40 | |
LATAM($M) | 6.71 | 4.97 | 5.87 | 6.61 | 5.56 | 5.93 | 5.11 | 5.90 | 5.56 | 5.31 | 4.48 | 4.89 | |
Products($M) | 99.9 | 91.4 | 91.9 | 87.7 | 87.4 | 78.8 | 74.7 | 71.2 | 73.2 | 71.1 | 69.1 | 63.7 | |
Aortic stent grafts($M) | 46.4 | 44.4 | 43.3 | 39.6 | 39.8 | 36.6 | 30.1 | 28.6 | 32.2 | 32.1 | 27.4 | 25.5 | |
On-X($M) | 30.5 | 26.0 | 27.8 | 26.8 | 25.6 | 21.6 | 22.2 | 21.5 | 20.6 | 19.7 | 20.2 | 18.7 | |
Preservation services($M) | 25.9 | 24.9 | 24.1 | 25.7 | 25.5 | 20.2 | 22.6 | 24.5 | 24.8 | 26.3 | 24.5 | 24.1 | |
Surgical sealants($M) | 19.3 | 18.8 | 20.3 | 18.9 | 19.3 | 18.1 | 19.9 | 18.4 | 18.5 | 17.0 | 18.5 | 16.2 | |
Other($M) | 3.70 | 2.29 | 0.46 | 2.39 | 2.74 | 2.52 | 2.40 | 2.69 | 1.83 | 2.35 | 3.01 | 3.25 | |
Earlier reporting (last reported 2023)3 | |||||||||||||
Medical devices($M) | 65.9 | 61.7 | 60.5 | 59.9 | 59.1 | 53.5 | 48.0 | 46.8 | 48.7 | 47.4 | 46.6 | 42.2 | |
Preservation services($M) | 14.6 | 13.7 | 12.6 | 14.5 | 14.0 | 10.0 | 13.5 | 14.2 | 14.7 | 15.6 | 14.5 | 14.1 | |
Products($M) | 65.9 | 61.7 | 60.5 | 59.9 | 59.1 | 53.5 | 48.0 | 46.8 | 48.7 | 47.4 | 46.6 | 42.2 | |
Preservation services($M) | 14.6 | 13.7 | 12.6 | 14.5 | 14.0 | 10.0 | 13.5 | 14.2 | 14.7 | 15.6 | 14.5 | 14.1 | |
18 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-07.
See a number that looks wrong?